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Metabolic syndrome in the elderly and its clinical implicationsMetabolic syndrome (MetS), a cluster of multiple cardiovascular
risk factors, has been recognized as an important predictor of
cardiovascular disease and type 2 diabetes mellitus.1 Although
the concept of MetS has been increasingly used in academic
researches,2–4 it is an empirical concept and the clinical utility is
often challenged, especially in the elderly.5 In fact, the majority of
previous observations obtained from middle-aged subjects, which
raises the question of whether MetS maintains prognostic value
in the elderly population. Additionally, different criteria used in
deﬁning MetS vary greatly that make comparisons difﬁcult.
A previous cross-sectional study demonstrated the association
of MetS and ischemic heart disease in the US geriatric population.6
Another study reported that MetS is a signiﬁcant predictor of athe-
rothrombotic stroke in older Japanese, but MetS in this study was
deﬁned by National Cholesterol Education Program Adult Treat-
ment Panel III (NCEP-ATPIII) and the World Health Organization
(WHO) criteria with modiﬁcation that differ from current criteria.7
However, in that study, central obesity was deﬁned by body mass
index and maximal thickness of peritoneal fat while high blood
pressure was surrogated by hypertension (blood pressure S140/
90 mmHg or taking antihypertensives). Rathmann et al., compared
three different diagnostic criteria (NCEP, WHO and IDF) for MetS
among older German, showed a weaker association of IDF-deﬁned
criteria to atherosclerosis risk (surrogated by serum C-reactive
protein) and authors proposed a need of new IDF criteria in older
adults in order to avoid underestimation of future risks for type 2
diabetes or cardiovascular disease.8
In the current issue of Journal of Clinical Gerontology & Geriat-
rics, Arai et al. compared different diagnostic criteria of MetS in the
elderly and middle-aged population in Japan.9 The study disclosed
three folds higher prevalence of MetS by using modiﬁed ATP III, IDF
and Japanese criteria in elderly women than middle-aged women
in which authors did not observe in men. These ﬁndings highlight
the greater impact of aging or menopause on development of MetS
in Japanese women. In addition, comparisons among three criteria
identiﬁed much higher prevalence of MetS by employing modiﬁed
ATP III or IDF criteria than Japanese stringent criteria used in Japa-
nese women. It could be accounted by unique criteria to diagnose
central obesity (waist circumference) in Japanese population. Other
ﬁndings from this study that aging plays certain roles in the blood
pressure, hyperglycemia and lipid proﬁle do not deviate frommajor
studies from other part of the world.
Recent studies have suggested that MetS per se in the elderly
may be less important, in which one single risk factor has the
same or even a greater prognostic value than MetS and the impor-
tant predictors of long-term costs in the elderly population were2210-8335 Copyright  2010, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. P
doi:10.1016/j.jcgg.2010.11.002abdominal obesity, low HDL-cholesterol and hypertension but
not MetS.10 Moreover, hyperglycemia has been shown to poten-
tiate excess mortality risk associated with lipid abnormality in
older adults, and the importance of optimal management of dysli-
pidemia and hyperglycemia in the elderly should be addressed.11 It
is generally agreed that the early identiﬁcation of MetS is still
important in clinical practice because the concept of MetS may
facilitate clinicians to take a strategy-based approach aimed at
reducing global cardiovascular risk. Moreover, clinicians should
encourage elderly patients to abandon sedentary lifestyles by
participating more in physical activities as part of primary preven-
tion of MetS.
Aside from cardiovascular diseases, MetS has been shown to be
associated with several geriatric problems. Both the prevalence of
cognitive impairment and MetS increase with advancing age and
previous studies found an association of MetS and cognitive impair-
ment among older adults.12,13 Similar result has been observed in
elderly Chinese and hyperglycemia was considered the main
contributor to this association.14 The complex interrelationship
deserves further investigations. In addition, MetS is also associated
with depressive symptoms in community-dwelling older adults,
especially in older women.15 A number of psychosocial risk factors
have been reported to be associated with MetS in the elderly, such
anxiety symptoms, negative life events, inadequate emotional
support and a high psychosocial risk index.16 Moreover, MetS was
signiﬁcantly correlated with physical dependence in terms of basic
and instrumental activities of daily living and low health-related
quality of life.17 Recent literature also indicated the associations
between MetS and cancer development which often occur in
elderly subjects.18
In summary, MetS in older adults is associated with cardiovas-
cular events, as well as physical dependence, cognitive dysfunction,
depressive symptoms, anxiety symptoms, high psychosocial risk
index, and poorer health-related quality of life. Therefore, the
beneﬁt of early identifying MetS in older adults is beyond cardio-
metabolic health, and appropriate management of MetS is of great
importance in promoting health and successful aging for older
adults.
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